185 related articles for article (PubMed ID: 21663645)
1. CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.
Ye ZJ; Zhou Q; Zhang JC; Li X; Wu C; Qin SM; Xin JB; Shi HZ
Respir Res; 2011 Jun; 12(1):77. PubMed ID: 21663645
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.
Ye ZJ; Zhou Q; Du RH; Li X; Huang B; Shi HZ
Clin Vaccine Immunol; 2011 Oct; 18(10):1608-15. PubMed ID: 21813663
[TBL] [Abstract][Full Text] [Related]
3. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
[TBL] [Abstract][Full Text] [Related]
4. Human CD39
Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
6. Th17/Treg imbalance in malignant pleural effusion.
Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703
[TBL] [Abstract][Full Text] [Related]
7. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
8. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
9. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ; Zhou Q; Gu YY; Qin SM; Ma WL; Xin JB; Tao XN; Shi HZ
J Immunol; 2010 Nov; 185(10):6348-54. PubMed ID: 20952674
[TBL] [Abstract][Full Text] [Related]
10. Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.
Zhou Q; Yan J; Putheti P; Wu Y; Sun X; Toxavidis V; Tigges J; Kassam N; Enjyoji K; Robson SC; Strom TB; Gao W
Am J Transplant; 2009 Oct; 9(10):2303-11. PubMed ID: 19656134
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Kinoshita M; Kobayashi S; Gotoh K; Kubo M; Hayashi K; Iwagami Y; Yamada D; Akita H; Noda T; Asaoka T; Takeda Y; Tanemura M; Eguchi H; Urakawa S; Goto K; Maekawa K; Wada H; Mori M; Doki Y
Dig Dis Sci; 2020 Oct; 65(10):2937-2948. PubMed ID: 31853779
[TBL] [Abstract][Full Text] [Related]
12. TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis.
Peres RS; Donate PB; Talbot J; Cecilio NT; Lobo PR; Machado CC; Lima KWA; Oliveira RD; Carregaro V; Nakaya HI; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; Cunha FQ
J Autoimmun; 2018 Jun; 90():49-58. PubMed ID: 29426578
[TBL] [Abstract][Full Text] [Related]
13. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes.
Cortez-Espinosa N; Cortés-Garcia JD; Martínez-Leija E; Rodríguez-Rivera JG; Barajas-López C; González-Amaro R; Portales-Pérez DP
Hum Immunol; 2015 Sep; 76(9):622-30. PubMed ID: 26386144
[TBL] [Abstract][Full Text] [Related]
14. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
[TBL] [Abstract][Full Text] [Related]
15. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
[TBL] [Abstract][Full Text] [Related]
16. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.
Chen YQ; Shi HZ; Qin XJ; Mo WN; Liang XD; Huang ZX; Yang HB; Wu C
Am J Respir Crit Care Med; 2005 Dec; 172(11):1434-9. PubMed ID: 16151041
[TBL] [Abstract][Full Text] [Related]
18. CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.
Liberal R; Grant CR; Ma Y; Csizmadia E; Jiang ZG; Heneghan MA; Yee EU; Mieli-Vergani G; Vergani D; Robson SC; Longhi MS
J Autoimmun; 2016 Aug; 72():102-12. PubMed ID: 27210814
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.
Longhi MS; Liberal R; Holder B; Robson SC; Ma Y; Mieli-Vergani G; Vergani D
Gastroenterology; 2012 Jun; 142(7):1526-35.e6. PubMed ID: 22387392
[TBL] [Abstract][Full Text] [Related]
20. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
